France Restricts New Obesity Drugs Amid Rising GLP-1 Demand and Safety Warnings
France is implementing stricter regulatory boundaries on the distribution of new anti-obesity medications, including GLP-1 receptor agonists, following an exponential surge in national demand. Driven by rapid uptake across pharmacies … Read More